Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement with Nuance Pharma in East and South East Asia
September 16, 2024 08:30 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Nuance Pharma successfully launched Bentrio® nasal spray for protection against airborne particles in Hong Kong and filed request for marketing...
Altamira Therapeutics Announces Extension of Bentrio Distribution Agreement with Pharma Nordic to Include Sweden and Denmark
August 23, 2024 09:01 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Successful launch of Bentrio by Pharma Nordic AS in Norway in 2024Exclusive distribution agreement extended to also include Sweden and Denmark ...
Altamira Therapeutics Announces Confirmed Suitability of Bentrio for Athletes as Comprehensive Testing Shows Absence of Prohibited Substances
August 16, 2024 09:01 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Independent analytical testing of Bentrio for > 230 prohibited substances of WADA list found none of themOutcome further confirms Bentrio’s...
Insignis Therapeutics Receives FDA Fast Track Designation for IN-001 for Anaphylaxis Treatment
August 13, 2024 07:30 ET
|
Insignis Therapeutics, Inc.
Insignis’ liquid epinephrine sublingual spray for anaphylaxis, stable and usable under both extreme heat and cold, gains FDA Fast Track designation.
Halberd Corp’s (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results
July 24, 2024 08:00 ET
|
Halberd Corp.
Halberd Corp’s (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results
Migraine Nasal Spray Market Forecast to Reach $621.6 Million by 2030: Global Analysis by Formulation, Packaging, Dosage, Distribution Channel, and Region
May 16, 2024 09:11 ET
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Migraine Nasal Spray Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...
Global Inhalation and Nasal Spray Generic Drugs Research Report 2024: Asthma Treatment Takes the Lead, Bronchodilators Dominates the Market - Forecasts to 2034
January 31, 2024 09:50 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Inhalation And Nasal Spray Generic Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's...
Nasal Allergy Treatment Market: Anticipating a Reach of US$ 21.4 Billion by 2032, Projected for Substantial Growth at a 4% CAGR from 2022 to 2032 | Persistence Market Research
January 10, 2024 09:48 ET
|
Persistence Market Research
New Yor, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global nasal allergy treatment market is poised for steady growth, driven by the increasing prevalence of allergic rhinitis, a chronic inflammatory...
Global Nasal Spray Market to Surge to $16.85 Billion by 2031, Driven by Rising Demand for Non-Invasive Drug Delivery
September 01, 2023 09:33 ET
|
Research and Markets
Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Nasal Spray Market By Type, By Application, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...
Nasal Spray Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand and Sales Forecast
August 22, 2023 05:00 ET
|
Fortune Business Insights
Pune, India, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Based on a report published by Fortune Business Insights, titled "Nasal Spray Market Size, Share, and Global Trends by Type (Salt Water Solutions,...